Literature DB >> 4765368

Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.

I L Weissman.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4765368

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. II. Lyt-1+2- T cells have potential to reject antigenically irrelevant (bystander) tumor cells on activation with the specific target tumor cells.

Authors:  T Yoshioka; H Fujiwara; Y Takai; M Ogata; J Shimizu; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 2.  Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke.

Authors:  Irving Weissman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

3.  IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.

Authors:  Bin Zhang; Theodore Karrison; Donald A Rowley; Hans Schreiber
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells.

Authors:  A R Moser; L L Johnson; W F Dove
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.